THE GROUNDS OF CLARITROMYCIN USE IN THE TREATMENT OF PSORIASIS

Abstract. Claritromycin influence on the keratinocytes proliferation and differentiation and lymphocytes proliferation and clasters of differentiation expression in vitro was investigated. It was established that claritromycin in dose 2 mkg/ml inhibited psoriatic keratinocytes proliferation and incr...

Full description

Saved in:
Bibliographic Details
Main Author: V. L. Rybkina
Format: article
Language:RU
Published: SPb RAACI 2014
Subjects:
Online Access:https://doaj.org/article/4f954af23b7940bcb3becb04bc612d13
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract. Claritromycin influence on the keratinocytes proliferation and differentiation and lymphocytes proliferation and clasters of differentiation expression in vitro was investigated. It was established that claritromycin in dose 2 mkg/ml inhibited psoriatic keratinocytes proliferation and increased its differentiation degree in culture. Claritromycin influence was mediated by CD4+ lymphocytes. Furthermore, claritromycin in vitro decreased the number of СD25+ lymphocytes and spontaneous and PHA-induced lymphocytes proliferation for psoriatic patients. These data allow to include claritromycin in the treatment regimen of psoriasis.